During the past decade, Instituto Oftalmologico de Cordoba conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Instituto Oftalmologico de Cordoba" are "Geographic Atrophy" (2 trials), "Macular Degeneration" (2 trials) and "Geographic Atrophy Secondary to Age-related Macular Degeneration" (1 trials). Many other conditions were trialed in "Instituto Oftalmologico de Cordoba" in a lesser frequency.

Most popular intervention types in "Instituto Oftalmologico de Cordoba" are "Drug" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (2 trials), "APL-2" (1 trials), "Abicipar Pegol" (1 trials), "PEGCETACOPLAN (APL-2)" (1 trials) and "Ranibizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Oftalmologico de Cordoba" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Instituto Oftalmologico de Cordoba". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Instituto Oftalmologico de Cordoba, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Oftalmologico de Cordoba, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".